Royce & Associates’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.29M | Sell |
752,924
-93,846
| -11% | -$908K | 0.07% | 381 |
|
|
2025
Q1 | $12.6M | Sell |
846,770
-22,624
| -3% | -$337K | 0.14% | 229 |
|
|
2024
Q4 | $13M | Buy |
869,394
+166,300
| +24% | +$2.48M | 0.12% | 250 |
|
|
2024
Q3 | $13.5M | Buy |
703,094
+30,750
| +5% | +$588K | 0.12% | 238 |
|
|
2024
Q2 | $13.9M | Buy |
672,344
+29,278
| +5% | +$606K | 0.13% | 225 |
|
|
2024
Q1 | $12.1M | Buy |
643,066
+14,398
| +2% | +$271K | 0.11% | 272 |
|
|
2023
Q4 | $9.07M | Buy |
628,668
+94,600
| +18% | +$1.36M | 0.08% | 339 |
|
|
2023
Q3 | $9.27M | Buy |
534,068
+169,630
| +47% | +$2.94M | 0.09% | 314 |
|
|
2023
Q2 | $7.58M | Buy |
364,438
+75,083
| +26% | +$1.56M | 0.07% | 391 |
|
|
2023
Q1 | $6.81M | Sell |
289,355
-63,400
| -18% | -$1.49M | 0.07% | 416 |
|
|
2022
Q4 | $9.85M | Sell |
352,755
-11,254
| -3% | -$314K | 0.1% | 296 |
|
|
2022
Q3 | $8.52M | Sell |
364,009
-19,800
| -5% | -$463K | 0.1% | 304 |
|
|
2022
Q2 | $13M | Sell |
383,809
-18,300
| -5% | -$618K | 0.13% | 226 |
|
|
2022
Q1 | $14M | Sell |
402,109
-110,946
| -22% | -$3.88M | 0.12% | 259 |
|
|
2021
Q4 | $15.6M | Sell |
513,055
-7,400
| -1% | -$225K | 0.12% | 271 |
|
|
2021
Q3 | $17.1M | Sell |
520,455
-26,348
| -5% | -$864K | 0.13% | 245 |
|
|
2021
Q2 | $16.5M | Buy |
+546,803
| New | +$16.5M | 0.11% | 311 |
|